Local and systemic complications of local anesthesia administration in dentistry
contents :
Introduction
Types of complications
Localized complications with their management
Generalized complications with their management
Local anaesthesia for children (dentistry)jhansi mutyala
When pain free reliable local anaesthesia is achieved in children confidence is gained by both the child and operator, and a sound satisfactory professional relationship is established. it includes all new tecniques of LA how to use them and their complications, composition, dosage, mechanisam of action
Local anaesthesia for children (dentistry)jhansi mutyala
When pain free reliable local anaesthesia is achieved in children confidence is gained by both the child and operator, and a sound satisfactory professional relationship is established. it includes all new tecniques of LA how to use them and their complications, composition, dosage, mechanisam of action
brief description on posterior superior alveolar nerve block.
its uses in dentistry, technique and action. locating PSA nerve is easy and this is the most used nerve block in dentistry.
We in Chinthamani Laser Dental Clinic & Implant Centre ,cover every speciality and subspeciality in dentistry so that all kind of your dental problems can be treated efficiently and effectively.
Contact us:
Chinthamani Laser Dental Clinic & Implant Centre
1/464,Mount Poonamallee High Road,
Iyyapanthangal,
Chennai-56
Phone no.044-43800059 , 92 83 786776
Email:
chinthamanidental@gmail.com,
dr_mrgvl@gmail.com
Website:
www.chinthamanilaserdentalclinic.com
brief description on posterior superior alveolar nerve block.
its uses in dentistry, technique and action. locating PSA nerve is easy and this is the most used nerve block in dentistry.
We in Chinthamani Laser Dental Clinic & Implant Centre ,cover every speciality and subspeciality in dentistry so that all kind of your dental problems can be treated efficiently and effectively.
Contact us:
Chinthamani Laser Dental Clinic & Implant Centre
1/464,Mount Poonamallee High Road,
Iyyapanthangal,
Chennai-56
Phone no.044-43800059 , 92 83 786776
Email:
chinthamanidental@gmail.com,
dr_mrgvl@gmail.com
Website:
www.chinthamanilaserdentalclinic.com
Periodontal surgery employs techniques that include intentional severing or incising of gingival tissues. The rationale of periodontal surgery is accessibility and visibility. The main goal of periodontal surgery is to eliminate infected pockets that do not respond to non surgical periodontal therapy. It also create conditions which allow for efficient plaque control.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
3. Introduction
Local anesthetics allow dentistry to be practiced without patient discomfort.
However, regardless of appropriate preanesthetic patient assessment, good
patient communication, and use of proper technique according to all the
recommended guidelines and procedures prior to the administration of the
local anesthetic agent, localized and systemic responses to anesthetic
injections are uncommon but may occur.
4. Serious complications associated with the use of these
drugs are rare.
The toxicity of local anesthesia can be local or systemic.
Systemic toxicity of anesthetics most often involves the
central nervous system (CNS) or/and the cardiovascular
system.
5. Definitions :
Complications is any deviation from the normally expected
pattern during or after securing local analgesia
Localized complications occur in the region of the injection and
can be attributed to the anesthetic needle, administration
technique, and/or to the anesthetic drug administered.
Systemic complications occur in the systems of the body and
are attributed to the drug administered such as hypersensitivity
and allergy or overdosage and toxicity
6. Classifications :
According to Bennett, there are three primary categories for
local anesthetic complications :
1. Primary or secondary
2. Mild or severe
3. Transient or permanent
7. 1. Primary or secondary
Primary complication,such as burning during the injection,
is experienced by the patient at the time of the injection.
The patient experiences the burning sensation at the time of drug administration.
Secondary complicationis apparent after the injection is completed.
It is caused by the injection of the local anesthetic drug,
but experienced by the patient later.
This could occur shortly after the injection or later.
8. 2. Mild or severe
Mild complicationsresolve without requiring treatment.
For example, burning during injection is temporary and resolves shortly after
the deposition of the solution.
Severe complications require a plan of treatment to resolve the
complication.
For example, anaphylaxis requires immediate treatment and drug intervention.
9. 3. Transient or permanent
Transient complications may appear severe at the time of their
observance but will eventually resolve without any residual effect.
For example, a hematoma may cause severe swelling and bruising, but will
resolve over time without leaving any residual effects.
Permanent complications leave a residual effect.
For example, nerve damage associated with the inferior alveolar (IA) local
anesthetic block may last a few weeks, months, or indefinitely.
10. Also Complications of LA can be categorized as :
• Doctor factor (wrong technique) or administration technique
• Vasoconstrictor or the anesthetic solution
• LA Needle ( anesthetic needle )
• Patient factor
Or can be categorized as :
• Local complications
• Systemic complications
14. Pain on injection
Causes :
pH of LA(~pH 5.0) (LA with VC is acidic (3.2 Painful, LA without
VC is less acidic (6.8)
Temperature of LA >15 – 37< is not detected by the patient
Rapid injection technique , faster injection is painful ( a rate of
60 sec. per cartridge is ideal)
Contamination with alcohol
15. Cont causes of pain on injection
Touching periosteum
Intraepithelial injection leading to ballooning
Subperiosteal injection cause discomfort due to
injection into noncompliant tissues
Careless technique
16. Prevention
Careful technique
Sharp needles
Topical anesthetic
Slow injections(a rate of 60 sec per cartridge is ideal)
Room temperature solutions
18. Needle breakage
Causes :
Unexpected movement by patient
Needle size (small , short )
Needle manipulation ,
i.e. bending the needle
Defective needle
19. Prevention of Needle Breakage
Patient communication
The dentist should thoroughly explain the procedure before the injection is administered,
and continue the communication throughout the procedure, helping the patient anticipate
the dentist’s actions.
in which will help alleviate the patient’s fear of the unknown
reduce the possibility of sudden unexpected movements.
Long, large-gauge needle
Long, 25-gauge needles should be used when penetrating significant soft tissue because they
are less likely to break than thinner, smaller-gauge needles.
Documented incidences of needle breakage have been reported predominantly when 30-
gauge, and occasionally 27-gauge, needles are used.
SO Do not use 30-gauge needles for IANBs in adults or children.
20. Do not bend needle
All intraoral injections can be performed successfully
without bending the needle.
Bending the needle weakens its integrity,
increasing the possibility of breakage.
prevents the proper recapping of the needle
Which
increasing the likelihood of post exposure accidents
21. Advance needle slowly
Slow advancement of the needle results in gentle contact of the
bone, decreasing the possibility of needle breakage.
In addition,
sudden forceful bone contact may startle the patient,
causing sudden unexpected movement.
Never force needle
The needle should never be forced against significant resistance
such as bone.
22. No sudden direction changes
Changes in needle direction should never be initiated when the needle is inserted
deeply in soft tissue.
The needle should be withdrawn almost completely and then redirected.
Never insert needle to hub
The most vulnerable part of the needle is at the hub,
THIS location where most needle breakages are likely to occur.
ALSO makes it virtually impossible to retrieve the needle
if breakage occur in such area
To increase the chances of retrieving a needle fragment, a portion of the needle’s
shaft in front of the hub should always be visible during the injection.
23. Treatment
If needle breakage occurs and the needle fragment is visible,
the following are recommendations for the dentist to follow:
1. Remain calm
If the patient senses panic, he or she will close the mouth,
causing the needle fragment to embed into the tissue.
2. Keep your hands in the patient’s mouth, and ask the
patient to open widely.
3. Attempt to remove it with the hemostat or cotton pliers.
24. If the needle fragment is not visible and cannot be retrieved,
the following are recommendations for the dentist to follow:
1. Remain calm, and inform the patient of the incident in a
manner that will alleviate his or her fear and apprehension.
2. The dentist, should refer the patient to an oral maxillofacial
surgeon for consultation and possible further treatment.
3. Document the incident and sequence of events in the
patient’s permanent record. It is important to include the
patient’s reaction to the situation.
4. Keep the remaining needle fragment for structural
evaluation.
25. 5. Surgical procedures are indicated if the needle
fragment is not deeply embedded in tissue and easily
located by radiographic or clinical examination.
6. If the needle is deeply embedded in tissue, the
maxillofacial surgeon may recommend that the needle
remain in the tissue without further attempt for removal.
26. Surgical removal
• A variety of methods have been described to locate a broken
needle in the pterygomandibular space.
• locating the retained fragment through panoramic and
computed tomographic (CT) scanning are often the
investigation of choice.
• CT scan should be the imaging investigation of choice, as it
accurately relays the position of the needle to recognizable
anatomical landmarks, especially with 3D reformatting
• Plain radiographs taken at right angles to each other are used
The most frequent combinations employed are a panoramic
radiograph and posterior anterior view of the mandible(PA) .
30. The incision
• The incision and site of exploration can be determined
from the information available on the CT scan,
• Most reports have suggested the use of a vertical
mucosal incision often on the medial aspect of the
mandible in the area penetrated by the needle, followed
by blunt supra-periosteal dissection to identify the
needle.
31. In the previous case
• Blunt dissection was used medially along the ramus to
expose the pterygomandibular space.
• A malleable retractor was used to protect the lingual and
inferior alveolar nerves.
• Further exploration of the pterygomandibular space was
performed using a microscope.
• The tip of the needle fragment was identified under the
microscope.
• The broken needle was removed using a hemostat forcep
32. TRISMUS
(limited mouth opening)
Causes
• IM Injection (Med. Pterygoid, temporalis)
• Hemorrhage
• Barbed needle
• Contamination by alcohol or sterilant
• Bacterial infection from the site of injection
33. This happens when the needle is inserted unintentionally
through the muscles resulting in its spasm.
This can happen to almost anyone regardless of their age
because dentists will have to depend on imagination to get
to the nerve correctly and start administering local
anesthesia.
Due to different location of bony landmarks and nerves in
individuals, a needle might be inserted through a muscle
accidentally
34. Trismus Prevention
• Sharp needles
• Proper care and handling of cartridges
• Aseptic technique and clean injection site
• Atraumatic insertion
• Minimal injections and volume
35. Treatment
Moist towel 20mins/hr
Management of trismus will require the patient to place a hot moist towels at
the site for approximately 20 minutes every hour
Physiotherapy
the patient should gradually open and close the mouth as means of physiotherapy.
R/O Infection
Muscle relaxants
Analgesics
analgesics might be prescribed
depending on the severity of pain.
36. Hematoma
Hematoma due to needle accidentally penetrate a b.v.
leading to effusion of blood into extravascular spaces
37. A hematoma develops when a blood vessel, particularly an artery,
is punctured or lacerated by the needle.
This is observed as asymmetrical swelling and discoloration of the
tissue resulting from the effusion of blood into extravascular spaces .
Hematomas particularly result after administration of a posterior
superior alveolar (PSA) block.
However, the inferior alveolar and mental nerve blocks also commonly
cause hematomas.
Hematomas less often occur after an infraorbital (IO) block,
because pressure is applied to the foramen immediately following the
injection.
Hematomas are least likely to develop following palatal blocks.
38. A, Hematoma producing initial swelling from administration of the right
posterior superior alveolar nerve block
B, Progression of hematoma one week following initial swelling.
39. Although hematomas may appear serious, they are more a
cosmetic nuisance. Trismus and mild pain may also occur.
A hematoma resulting from a PSA block is usually the largest
due to the infratemporal fossa being able to accommodate large
volumes of blood, and clinically appears as extraoral bruising.
Hematomas resulting from an IA block appear as intraoral
bruising.
40. Prevention
Although hematomas can occur even when proper technique is
used,
to decrease the risk the dentist should follow these guidelines:
1. Know your anatomy.
2. Use a short needle and modify the needle penetration depth for
the PSA block for children, petite adults, and patients with small
facial characteristics.
3. Minimize the number of needle insertions.
4. Follow all recommended injection techniques for all local
anesthetic injections.
41. Management of Hematoma
1. At the first sign of swelling, apply pressure directly to the area for a minimum of
2 minutes.
This involves the medial aspect of the mandibular ramus for the IA block, the
mental foramen for the mental/incisive block, and because it is difficult to locate
the blood vessels for the PSA block, pressure should be applied as far distally as
possible without producing a gag reflex.
2. Apply ice to the region of the developing
hematoma to reduce the swelling.
Ice will constrict the blood vessels,
decreasing the effusion of blood into the
extravascular spaces,
and also provide some analgesic effects
for the patient.
42. 3. Inform the patient that soreness and limited movement of their jaw may occur.
Instruct the patient to use warm moist towels applied to the region the next day for 20
minutes every hour to assist in the resorption of blood.
Heat application (>6 hours post injection vasodilatory) should be avoided .
4. Inform the patient that there are no serious complications associated with
hematomas,
and that swelling and discoloration should disappear after 7–14 days.
5. Do not dismiss the patient until bleeding has stopped.
Document the incident in the patient’s record including instructions presented to the
patient, and the patient’s response.
6. When hematoma is large prescribe antibiotics to prevent infection
7. Analgesics and follow up as indicated.
44. Temporary facial nerve paralysis is caused by the
inadvertent deposition of local anesthetic solution
during the inferior alveolar (IA) block into the parotid
gland, anesthetizing the facial nerve that runs through
the parotid gland
This is due to over insertion of the needle penetrating
the parotid gland.
This produces a unilateral loss of motor function
to the facial expression muscles.
45. The patient might not
be able to smile,
or close the eyelid,
when they are asked to do so,
on the affected side
A, Inability to close eyelid.
B, Drooping of lip on affected
side (patient’s left).
46. Treatment
1. Reassure the patient
At the point of muscle weakening, the patient will be alarmed
and immediate reassurance is necessary to alleviate the
patient’s fears.
Reassure the patient that the paralysis is only temporary and
will last only a few hours.
Explain that weakness in the muscles will resolve as soon as the
anesthetic action fades.
47. 2. Protect cornea
Ask the patient to remove contact lenses if applicable and to manually close his or
her eye.
Although the corneal reflex remains functional, this will assist in keeping the
cornea lubricated.
The eye on the affected side should therefore be protected
and covered by an eye-shield or eye-pad.
A drops of sterile paraffin or (Saline Eye Drops )
might be administered to help protect the cornea
48. 3. There are no contraindications to completing the scheduled
treatment.
However, it may be advisable to reschedule treatment for a different
time.
This should be determined on an individual basis and predominantly depends on
the patient’s reaction to the situation.
If treatment is to be continued, the IA block must be completed
reinjected because the target site was missed during the first
injection.
4. Document the incident and the patient’s reaction in the patient’s
chart.
5. Follow-up as indicated.
49. Persistent Paresthesia/Anesthesia
Injury to a nerve where the patient experiences
a sudden sharp and electrical pain.
This happens most frequently where the injection was very accurate and the
needle has touched the nerve.
If the nerve is damaged in any case, the anesthetic effect might persist for weeks
or even months or permanent loss of sensation if the impact has resulted in a
permanent damage to the nerve.
50. Causes :
Trauma to nerve sheath OR Intraneural injection
paresthesia may be caused by trauma to the nerve sheath resulting
from the needle contacting the nerve during its insertion or
removal from the tissues.
This occurs most commonly with the lingual nerve producing
a sensation of an electrical shock when it occurs.
Hemorrhage around neural sheath
Hemorrhage around the nerve sheath may also contribute to
paresthesia by creating excessive pressure on the nerve
51. Neurolytic agents (alcohol, phenol)
Paresthesia may be a result of irritation to the nerve following the
administration of a contaminated local anesthetic solution with
alcohol or other disinfectants.
Edema caused by the irritation places pressure on the nerve, resulting
in prolonged anesthesia.
The observed frequencies of paresthesia following the administration
of articaine (p < 0.002) or prilocaine (p < 0.025) were significantly
greater than the expected.
These results are consistent with the suggestion that local anesthetic
formulations may have the potential for mild neurotoxicity.
52. To prevent paresthesia
To prevent paresthesia, local anesthetic cartridges should be
stored properly in their original containers.
• Cartridges should never be placed in disinfecting solution,
• Injection techniques should be used as recommened
Most paresthesia is not serious and will typically resolve within
8 weeks.
It most commonly occurs with the lingual and inferior alveolar
nerve and produces only minimal sensory deficit. Fortunately,
permanent nerve damage rarely occurs
53. Management
1. Reassure the patient.
The patient will typically call the dental office the day after the procedure
concerned about the prolonged numbness.
Reassure the patient that paresthesia is not uncommon following the
administration of local anesthetics.
2. Arrange for the patient to be examined
to determine the extent of paresthesia.
• Instruct the patient that paresthesia may last up to 2 months and perhaps
longer.
• Inform patient of normal signs of nerve recovery
-Tingling
-Intermittent burning or sharp pain
54. 3. A vitamin B12 complexes might be prescribed to fasten the
time of healing.
4. Re-evaluate patient in 2 weeks
5. Document degree and extent
6. If symptoms persist, refer to OMFS
7. The patient should be examined by the dentist every 2
months until normal sensation returns.
8. Avoiding injections to the traumatized nerve.
Alternative pain control measures should be taken.
56. This happens after anesthesia where the patient is not
instructed not to bite on his/her lips for 2-3 hours
to compensate for duration of the anesthesia
as the patient will not have any kind of sensation in
his/her lips and might unintentionally bite on it for a
long period of time leading to an ulcer
Children and MR at high risk
• Use short-acting LA
• Instructions
• Close observation
57. Treatment
• The mistake here lies back to the dentist of not
informing the patient or instructing not to bite in
his/her lips.
• If this incident occurs however, the ulcer will heal by
itself in 10-15 days.
It might take longer depending on the severity of the
ulcer but, in general, it heals by itself
Analgesics might be prescribed to alleviate pain and
inflammation.
59. • Resemble HSV outbreak
• Appears after 2 days from LA administration
Causes :
• Local tissue trauma/hypoxia/necrosis
• Activation of HSV
Treatment
• Reassure patient
Self limiting 10-14 day course
• Analgesics
61. Cause
• Prolonged use of topical anesthetic
• High concentration of vasoconstrictors
Predominantly in palatal mucosa
Treatment
• Resolution in 7-10 days
• Analgesics
• Saline rinses or Peridex
• Petrolatum can be used to
coat the area to minimize
discomfort
62. Failure anesthesia
Causes :
• Wrong technique
• Anatomical variations: Bifid MC (double nerve supply)
and Retromolar canal
or Nerve anastomosis Secondary supply by a soft tissue
nerve: LN, LBN & GPN
• Inadequate dose or Sepsis acidity
• Anxiety reduced patient pain threshold (Patient
immaturity)
63. Management of failed local anesthesia
• Check anatomical landmarks
• Repeat injection
• Consider alternate or additional technique
• Consider whether anxiety may be contributory
factor for pain and try again about a week later
64. Infection
Infection around the area of needle penetration
Or deep in the tissue
Causes :
• Contamination of the anesthetic needle before injection
• Improper handling of local anesthetic
• Administration of contaminated solution
• Administering local anesthetics through areas of dental
infection
Treatment
• Antibiotics should be prescribed
• Analgesics for pain
66. • Systemic toxicity of local anesthetics can occur after
administration of an excessive dose, with rapid absorption, or
because of an accidental intravenous injection. The
management of local anesthetic toxicity can be challenging,
and in the case of cardiac toxicity, prolonged resuscitation
efforts may be necessary.
• Therefore, understanding the circumstances that can lead to
systemic toxicity of local anesthetics and being prepared for
treatment is essential to optimize the patient outcome.
67. • Systemic toxicity is typically manifested as central nervous system (CNS)
toxicity (tinnitus, disorientation, and ultimately, seizures) or
cardiovascular toxicity (hypotension, dysrhythmias, and cardiac arrest).
• The dose capable of causing CNS symptoms is typically lower than the
dose and concentration result in cardiovascular toxicity. This is because
the CNS is more susceptible to local anesthetic toxicity than the
cardiovascular system. However, bupivacaine toxicity may not adhere to
this sequence, and cardiac toxicity may precede the neurologic symptoms.
• Although less common, cardiovascular toxicity is more serious and more
difficult to treat than CNS toxicity.
68. These complications may caused by:
• direct extension of the usual pharmacological effects of
the drugs :
1. Side effects
2. Overdose
3. Local toxic effect
• caused by alteration in recipient of the drug
1. Disease process ( hepatic dysfunction ,CHF, renal
dysfunction )
2. Emotional disturbance
3. Genetic aberrations (Atypical plasma cholinesterase )
• caused by allergic response to the drug
69. Systemic Complications Of Local Anesthesia are :
1. Toxicity due to overdose
2. Allergy Anaphylactic reactions
3. Idiosyncrasy
4. Syncope
5. Drug interaction
6. Serum hepatitis
7. Respiratory arrest
8. Cardic arrest
9. Hyperventilation
10.Infection to more distant areas
70. local anesthetic toxicity
While generally safe, local anesthetic agents can be
toxic if administered inappropriately, and in some cases
may cause unintended reactions even when properly
administered. Adverse effects are usually caused by high
plasma concentrations of the agent, which may result
from one of the following:
• Inadvertent intravascular injection
• Excessive dose or rate of injection
• Delayed drug clearance
• Administration into vascular tissue
71. Predisposing factors
Patient factor Drug factor
1. Vasoactivity
2. Concentration
3. Dose
4. Route of administration
5. Vascularity of injection site
6. Presence of vasoconstrictor
7. Rate of injection
1. Age
2. Weight
3. Other drug
4. Sex
5. Genetics
6. Mental attitude and
environment
72. Predisposing factors to toxic reactions to
the local anesthetic itself include:
Age a Patients under 6 years and over 65 years of age
- Absorption, metabolism, and excretion are not fully
developed before age 6, and these functions diminish
after age 65.
73. Patient’s weight
Underweight patients, especially those with little
muscle mass –
Drugs are calculated on mg of drug/per kg, or pound
of weight
The less an individual weighs and the less muscle
mass he has, the lower the tolerance to the drug.
74. Liver disorders
Liver damage causes local anesthetic to build up in the blood.
Most local anesthetics are biotransformed in the liver and
broken down to products that can be eliminated from the body
by the kidneys.
patients with reduced hepatic function may exhibit an
abnormally decreased rate of metabolism of amide local
anesthetics, resulting in potentially toxic blood levels.
Dosage levels must therefore be reduced for these patients
75. For example, because lidocaine is hepatically
metabolized,
liver dysfunction increases the risk of toxicity.
Because lidocaine is also protein bound, low protein
states may also increase risk
In such cases, local anesthesia should be used
judiciously and in consultation with the patient`s
physician.
76. Genetic factor
Pseudocholinesterase deficiency:
• Pseudocholinesterase deficiency is an inherited blood plasma
enzyme abnormality in which the body's production
of butyrylcholinesterase ( pseudocholinesterase) is impaired.
• People who have this abnormality may be sensitive to certain
anesthetic drugs, including the muscle relaxants
succinylcholine and mivacurium as well as other ester local
anesthetics.
local anesthetics of the ester type (eg, procaine) should be
avoided in patients who have this rare familial enzyme defect .
77. • Dentists should be aware of the importance of
avoiding ester local anesthetics in patients with
pseudocholinesterase deficiency.
• Although ester local anesthetics are not commonly
used in clinical practice, they are often employed
when a patient has a suspected allergy to amide
local anesthetics or where vasoconstrictors are
contraindicated.
78. • A personal or family history of an adverse drug reaction to
one of the choline ester compounds, such as succinylcholine,
mivacurium, or cocaine, may be the only clue suggesting
pseudocholinesterase deficiency.
• This condition is recognized most often when respiratory
paralysis unexpectedly persists for a prolonged period of time
following administration of standard doses of
succinylcholine.
• The mainstay of treatment in these cases is ventilatory
support until diffusion of succinylcholine from the
myoneural junction permits return of neuromuscular
function of skeletal muscle.
• The diagnosis is confirmed by a laboratory assay
demonstrating decreased plasma cholinesterase enzyme
activity.
79. Acid-base status
Acid-base status plays an important role in the setting of local anesthetic toxicity
Acidosis and hypercarbia amplify the CNS effects of local anesthetic overdose and
exacerbate cardiotoxicity.
Hypercarbia enhances cerebral blood flow; consequently, more local anesthetic is
made accessible to the cerebral circulation.
Diffusion of carbon dioxide across the nerve membrane can cause intracellular
acidosis, and as such, it is promoting the conversion of the local anesthetic into the
cationic, or active, form. Because it is impossible for the cationic form to travel
across the nerve membrane, ionic trapping occurs, worsening the CNS toxicity of the
local anesthetic.
Hypercarbia and/or acidosis also reduce the binding of local anesthetics by plasma
proteins, and as a result, the fraction of free drug readily available for diffusion
expands
80. Interactions with other drugs (eg, cimetidine, beta-
blockers) can also affect lidocaine drug levels
• There are interactions between epinephrine and
other drugs. The action of catecholamines is
potentiated by some drugs, e.g. tricyclic
• antidepressants, MAO inhibitors, antiparkinson
drugs, methyldopa, guanethidine. In patients, taking
those drugs, dose of epinephrine must be reduced.
82. Kidney disorders - If the kidneys can not eliminate the
byproducts of local anesthetics, there can be toxic
accumulations in the blood.
Pregnancy - During pregnancy, renal function can be
disturbed. This can impair excretion and result in an
increased blood level of the local anesthetic.
• Bupivacaine has been shown to have increased
cardiotoxicity in pregnant women resulting in a
decreased CC/CNS dose ration.
83. Drug factors
• Various factors lead to toxic reactions to local anesthetics.
Local anesthetics have vasodilating properties, which increase
the possibility of overdose.
Low doses of local anesthetics may cause vasoconstriction, where as, moderate or high
doses result in vasodilation and decreased SVR. Cocaine is the only local anesthetic
thatcausesvasoconstrictionatalldoses.
• The amount of drug given should not be more than 1.1 dental
cartridges of 2 percent lidocaine per 20 pounds of body
weight.
More than that amount increases the chances of toxic overdose.
84. The rate of injection
The rate of injection is the most important factor in
preventing overdose. A rapid injection (30 seconds or
less) causes rapid blood levels, which increases the
chance of overdose.
So , Injections should be administered slowly
(60 seconds or more for administration of a 1.8 mL cartridge).
This produces a low blood level, which decreases the
chance of overdose
85. Anothercauseoftoxicoverdoseisintravascularinjection
• which occurs when the anesthetic is unintentionally injected directly
intoabloodvessel.Bothinterarterialandintravenousinjections may
produceoverdosereactions.
• Intravascular injection is usually prevented by using an aspirating
syringe. A return of blood into the dental cartridge is considered a
positive aspiration. Even if there is no return of blood into the dental
cartridge, there is still a risk of intravascular injection if the injection
isadministeredrapidlyandincloseproximitytoacapillarybed.
86. Vasoconstrictorsareimportant
• The mouth is highly vascular, making absorption of local anesthetic into
the blood more rapid than at other sites. This is why the presence of a
vasoconstrictorinlocalanestheticsissoimportant.
• The vasoconstrictor counteracts the vasodilating properties of blood
vesselsanddecreasestherateofsystemicabsorption.
87. • The most common vasoconstrictor is epinephrine. Epinephrine should
not be used on patients who take a variety of medications; however,
there is a greater risk of medical emergency if local anesthesia is
administeredwithoutit.
• The most common adverse drug reaction with local anesthesia is not a
reaction or drug interaction with epinephrine - it is local anesthesia
toxicity.
• If epinephrine is contraindicated for a patient, the local anesthetic
mepivicaine (Carbocaine) is a good alternative. It is slower to dissipate
fromtheinjectionsiteanddoesnotcontainavasoconstrictor.
89. Minimum Intravenous Toxic Dose of Local
Anesthetic in Humans
Agent Minimum Toxic Dose (mg/kg)
Procaine 19.2
Tetracaine 2.5
Chloroprocaine 22.8
Lidocaine 6.4
Mepivacaine 9.8
Bupivacaine 1.6
90. CNS toxicity
• CNS toxicity is biphasic.
• The earlier manifestations are due to CNS excitation,
with problems such as seizures.
• Subsequent manifestations include CNS depression with
a cessation of convulsions and the onset of
unconsciousness and respiratory depression or arrest.
91. Toxicity mechanisms
CNS toxicity from local anesthetics manifests initially as CNS
excitation, followed by CNS depression.
This biphasic effect occurs because local anesthetics first block
inhibitory CNS pathways (resulting in stimulation) and then
eventually block both inhibitory and excitatory pathways
(resulting in overall CNS inhibition).
92. Cardiovascular effects
• Cardiovascular effects occur at higher serum concentrations of
local anesthetics.
• These effects may include arrhythmias ,acceleration of the
ventricular rate has been reported in patients with atrial
arrhythmias
• Cardiovascular effects occur because these agents block sodium
channels through a fast-in, slow-out mechanism that affects
impulse conduction through the heart and nerve tissue.
• In the heart, this depresses Vmax (ie, the rate of depolarization
during phase 0 of the cardiac action potential) and may lead to
reentrant arrhythmias. Additionally, conduction through the sinus
and atrioventricular nodes is suppressed
93. History
• Manifestations of local anesthetic toxicity typically appear 1-5 minutes
after the injection, but onset may range from 30 seconds to as long as 60
minutes.
• Initial manifestations may also vary widely. Classically, patients experience
symptoms of central nervous system (CNS) excitement such as the
following:
• Circumoral and/or tongue numbness
• Metallic taste
• Lightheadedness
• Dizziness
• Visual and auditory disturbances (difficulty focusing and tinnitus)
• Disorientation
• Drowsiness
Although cardiac toxicity classically does not occur without preceding CNS
toxicity, numerous published case reports describe episodes limited to
cardiovascular manifestations. In these cases, onset of symptoms was delayed
by 5 minutes or more. [1]
94. Physical Examination
• After the use of local anesthetic agents, consider the
appearance of new signs or symptoms as a possible sign of
toxicity.
• The manifestation of toxicity depends on the organ system
or systems that are affected. Toxicity manifestations can
be categorized as follows:
• CNS
• Cardiovascular
• Hematologic
• Allergic
• Local tissue
95. Central nervous system manifestations
• With higher doses, initial CNS excitation is often followed by
a rapid CNS depression, with the following features:
• Muscle twitching
• Convulsions
• Unconsciousness
• Coma
• Respiratory depression and arrest
• Cardiovascular depression and collapse
96. • With progression of toxicity, the patient may experience tonic-
clonic seizures and, eventually, unconsciousness and coma.
• CNS symptoms may be masked in patients premedicated with
anticonvulsants such as benzodiazepines or barbiturates. The
first sign of toxicity in these premedicated patients may be
cardiovascular depression.
• When blood levels are high enough to block inhibitory and
excitatory pathways, convulsions cease and the patient may
experience respiratory depression or arrest and cardiovascular
depression.
• Large bolus injections may increase peak anesthetic levels to the
point where the CNS and cardiovascular system are affected
simultaneously.
97. Cardiovascular manifestations
• Risk of cardiovascular toxicity is somewhat greater with
lipophilic local anesthetics such as bupivacaine.
• Risk of cardiac toxicity is greatest in those patients with
underlying cardiac conduction problems or after myocardial
infarction.
• Toxic doses of local anesthetic agents can cause myocardial
depression (tetracaine, etidocaine, bupivacaine), cardiac
dysrhythmias (bupivacaine), and cardiotoxicity in pregnancy.
• Several anesthetics (eg, lidocaine) also alter vascular tone, with
low doses having vasoconstrictive effects and higher doses
causing relaxation of vascular smooth muscle, possibly leading
to hypotension.
98. The sequence of cardiovascular events is ordinarily as follows:
Low blood levels of local anesthetic usually generate a small increase in
cardiac output, blood pressure, and heart rate, which is most likely due to a
boost in sympathetic activity and direct vasoconstriction.
As the blood level of local anesthetic rises, hypotension ensues as a result of
peripheral vasodilation due to relaxation of the vascular smooth muscles.
Further rise of local anesthetic blood levels leads to severe hypotension,
resulting from the combination of reduced peripheral vascular resistance,
reduced cardiac output, and/or malignant arrhythmias.
Eventually, extreme hemodynamic instability may lead to cardiac arrest.
99. The range of signs and symptoms of cardiovascular
toxicity include the following:
• Chest pain
• Shortness of breath
• Palpitations
• Lightheadedness
• Diaphoresis
• Hypotension
• Syncope
100. • Effects on cardiac conduction include widened PR
interval, widened QRS duration, sinus tachycardia,
sinus arrest, and partial or complete atrioventricular
dissociation.
• Cardiac arrest has been reported after intraurethral
administration of lidocaine.
• Cardiac toxicity is potentiated by acidosis, hypercapnia,
and hypoxia, which worsen cardiac suppression and
increase the chance of arrhythmia.
• This is important to consider since seizure makes this
metabolic picture more likely.
101. Overdose
Overdose can be defined as those clinical signs and
symptoms that result from an overlay high blood level of
the drug in varous target tissue and organs
102. CLINICAL MANIFESTAIOTNS OF OVERDOSE
minimal to moderate overdose level :
Signs: Symptoms:
• Talkativeness
• Apprehension
• Slurred speech
• Excitability
• Stutter بالكالم تلعثم
• Euphoria
• Nystagmusاراديا ال العين مقلتي تذبذب
• Muscular twitching / tremors
• Elevated BP
• Sweating
• Elevated heart rate
• Nausea/vomiting
• Elevated resp. rate
• Disorientation
• Failure to follow commands /
reason
• Lack of response to painful stimuli
• Restless
• Visual disturbances
• Nervous
• Auditory disturbances
• Numbness
• Metallic taste
• Light-headed and dizzy
• Drowsy and disoriented
• Losing consciousness
• Sensation of twitching (before
actual twitching is observed)
103. Moderate to High overdose level :
Generalized tonic-clonic seizure activity
followed by
• Generalized CNS depression
• Depressed BP, heart rate
• Depressed respiratory rate
104. Pathophysiology
Local anesthetics cross blood-brain barrier, producing CNS depression as level rises
eg. LIDOCAINE
Blood Level Action Produced
• < .5 ug/ml
• 0.5-4 ug/ml
• 4.5-7.5 ug/ml
• > 7.5 ug/ml
• - no adverse CNS effects
• Anticonvulsant
• - agitation, irritability
• - tonic-clonic seizures
Local anesthetics exert a lesser effect on the cardiovascular system
eg. LIDOCAINE
Blood Level Action Produced
• 1.8-5 ug/ml
• 5-10 ug/mlx
• >10 ug/ml
• treat PVCs, tachycardia
• - cardiac depression
• - severe depression,
bradycardia, vasodilatation,
arrest
105. MANAGEMENT of OVERDOSE
Mild Reaction -slow onset
• Reassure patient
• Administer O2
• Monitor vital signs
• Consider IV anticonvulsant
• Allow recovery or get medical help
• Get medical consultation, esp. if possibility of metabolic or
renal dysfunction
106. Severe Reaction - rapid onset
• Stop all treatment
• Place patient in supine position, feet up
• Establish airway, give O2
• If convulsions, protect patient
• Call for emergency medical help
• Administer anticonvulsant drugs
• Consider vasopressors
• Get medical consultation, esp. if possibility of metabolic
or renal dysfunction
107. Vasoconstrictor Overdose Epinephrine Overdose
Clinical manifestations:
• Fear, anxiety
• Tenseness
• Restlessness
• Tremor
• Weakness
• Throbbing headache
• Dizziness
• Pallor
• Respiratory difficulty
• Palpitations
• Sharply elevated BP (systolic)
• Increased heart rate
• Cardiac tachyarrhythmias
Management :
• Stop dental treatment
• Sit patient up
• Reassure patient, administer O2
• Monitor BP and pulse until fully
recovered
108. Allergic Reactions
Can be of 2 types :
• Antigen induced occurs in sec/min(Angioedema,Anaphylaxis )
Or
• IV Cell mediated 48 hrs (Contact dermatitis)
109. Allergens in LA :
Esters - usually to the Para-amino-benzoic-acid product
Na bisulfite or metabisulfite - found in anesthetics as perservative for
vasoconstrictors
Methylparaben - no longer used as perservative in dental cartridges
Amino amides are not associated with PABA and do not produce
allergic reactions with the same frequency. However, preparations
of amide anesthetics may sometimes contain methylparaben, which
is structurally similar to PABA and thus may result in allergic
reactions.
112. Management of Allergic Reactions
Delayed skin reaction
Benadryl - 50 mg stat & Q6H X 3-4 days
Immediate skin reaction
Epinephrine 0.3 mg IM or SC
Benadryl - 50 mg IM
Observation, medical consultation
Benadryl - 50 mg Q6H X 3-4 days
113. Bronchial constriction
Semi-erect position, O2 - 6 L/min
Inhaler or Epinephrine 0.3 mg IM or SC
Benadryl - 50 mg IM
Observation, medical consultation
Benadryl - 50 mg Q6H X 3-4 days
Laryngeal edema
Place supine, O2 - 6 L/min
Epinephrine 0.3 mg IM or SC
Maintain airway
Benadryl - 50 mg IV or IM
Hydrocortisone - 100 mg IV or IM
Perform Cricothyrotomy
114. Anaphylaxis
1. Place supine, on flat surface
2. ABCs of CPR, call for medical help
3.Epinephrine 0.3 mg IV or IM (Q 10 mins)
4. O2 - 6 L/min, monitor vital signs
If no improvement give Epinephrine 0.3 mg IV or IM again in 10
mins
• Histamine blocker -50mg
• Diphenhydramine (Benadryl, 25-50 mg for adults, 1 mg/kg for
pediatric patients).
• OR 10 mg Chlorpheniramine corticosteriod
• Hydrocortisone 100mg IM/IV vi)
CPR After clinical un improvement, Benadryl and Hydrocortisone
115. Hematologic manifestations
Methemoglobinemia is a condition caused by elevated levels of methemoglobin in
the blood.
Methemoglobin is a form of hemoglobin that contains the ferric [Fe3+] form of iron.
The affinity for oxygen of ferric iron is impaired.
116. • Methemoglobinemia has been frequently reported in association with
benzocaine use;
• however, lidocaine and prilocaine have also been implicated. O-toluidine, the
liver metabolite of prilocaine, is a potent oxidizer of hemoglobin to
methemoglobin.
• At low levels (1-3%), methemoglobinemia can be asymptomatic, but higher
levels (10-40%) may be accompanied by any of the following complaints:
• Cyanosis
• Cutaneous discoloration (gray)
• Tachypnea
• Dyspnea
• Exercise intolerance
• Fatigue
• Dizziness and syncope
• Weakness
117. Adverse effects of topical
application
Topical anesthesia can produce systemic toxicity
118. • A variety of anesthetics are available for topical or
mucosal application (eg, tetracaine, benzocaine,
lidocaine, cocaine).
• Adverse effects from these agents typically occur
when they are applied to abraded or torn skin,
resulting in systemic absorption and high plasma
concentrations of the agent.
• Similarly, absorption of oral viscous lidocaine may
cause systemic toxicity, particularly with repeated
use in infants or children.
119. The following systemic reactions may occur with
topical anesthetics:
• CNS: High plasma concentration initially produces CNS stimulation (including
seizures), followed by CNS depression (including respiratory arrest); CNS
stimulatory effects may be absent in some patients, particularly with amides
(eg, tetracaine); epinephrine-containing solutions may add to the CNS
stimulatory effect
• Cardiovascular: High plasma levels typically depress the heart; effects may
include bradycardia, dysrhythmias, hypotension, cardiovascular collapse, and
cardiac arrest; epinephrine-containing local anesthetics may cause
hypertension, tachycardia, and myocardial ischemia
• Suppression of the gag reflex with oral administration
Other adverse effects include the following:
• Transient local burning or stinging sensation
• Skin discoloration
• Swelling
• Neuritis
• Tissue necrosis and sloughing
• Methemoglobinemia with prilocaine
120. Fainting or syncope
Fainting or syncope frequently occurs because
of patient frightened at the thought of
receiving an injection
121. Predisposing factors:
1-Psychogenic factors: fear , anxiety and sight of
unpleasant object as blood or surgical instrument
2-Non-psychogenic: factors as pain especially sudden
unexpected, sitting in waiting area for a long period,
hunger causing low glucose supply or exhaustion ,poor
physical condition
122. Clinical features
1-Pre-syncope period :
The patient feels faint and may feel nauseating. Paleness and coldness of hand,
cold sweating over the forehead and hands, hypotension , tachycardia and deep
irregular respiration Loss of consciousness: Hypotension , bradycardia and
shallow irregular respiration. Possible muscular twitches (tremors) or convulsive
movements of the extermities. Progression may occur into muscular relaxation
and apnoea
2-Post-syncope period After regaining consciousness the patient feels weak,
nauseating and mentally confused for few minutes.
123. Pathophysiology
Stress causes the secretion of adrenalin into the circulation
this cause
peripheral vascular resistance and blood flow to the
muscle to prepare body to response to this stressful
condition
124. Treatment
1-Stop any dental procedure
2-Place patient in supine or trendelenberg position to facilitate
venous return to the heart
3-Maintain patient airway , respiratory stimulants by aromatic
spirit of ammonia
4-Oxygen administration might be needed
5-Keep the patient in this position under observation 6-For
persistent bradycardia give atropine 0.4 mg i.v
125. Regional or systemic infection:
spread of infection within the perioral tissues can be
potentially spread through planes of the head and neck by
passage of a needle through an infected area.
* Endocarditis risk: injections such as the intraligamentary
injection can force bacteria into the systemic circulation
and cause bacterial endocarditis
127. Mechanism of Injury
• The mechanism by which bupivacaine might cause liver
injury is unknown, but is most likely due to an idiosyncratic
hypersensitivity reaction. The amide local anesthetics are
metabolized locally and do not affect the activity of
cytochrome P450 enzymes.
Management
• The liver injury linked to exposures to amide anesthetics has
largely been limited to use of bupivacaine given by infusion
or multiple injections over a period of 1 to 3 days.
• The injury was invariably self-limited, and no instance of
chronic liver injury, vanishing bile duct syndrome or acute
liver failure has been linked to bupivacaine or other local
anesthetics.
128. Local Anesthetic Toxicity Treatment & Management
• In the patient with suspected local anesthetic toxicity,
the initial step is stabilization of potential threats to life.
If the signs and symptoms develop during administration of the local anesthetic,
stop the injection immediately and prepare to treat the reaction.
Ensure adequate oxygenation, whether by face mask or by intubation.
• Attention to impending airway compromise, significant hypotension, dysrhythmias, and
seizures takes precedence.
• Once other possible etiologies of the patient's new symptoms have been excluded,
management of the specific symptoms can begin.
129. • Benzodiazepines are the drugs of choice for seizure
control.
• Propofol can be used to control seizures but has the risk
of potentiating cardiovascular toxicity.
• Refractory seizures may require neuromuscular blockade
(eg, with succinylcholine).
• In severe reactions, monitor the cardiovascular system
and support the patient with intravenous fluids and
vasopressors as required. Small bolus doses of
epinephrine are preferred. Vasopressin is not
recommended.
130. • Hypoxemia and metabolic acidosis may potentiate the
cardiovascular toxicity of lidocaine and other local anesthetics.
Early control of seizures and aggressive airway management to
treat hypoxemia and acidosis may prevent cardiac arrest.
Use of sodium bicarbonate may be considered to treat severe
acidosis.
• Cardiac arrest due to local anesthetic toxicity is a rare but well
recognized complication that may occur in cases of large
overdose, especially those involving inadvertent intravascular
injection. These patients have a favorable prognosis if circulation
can be restored before hypoxemic injury occurs. Aggressive
resuscitation is therefore indicated in most cases.
Cardiopulmonary bypass has been used effectively to treat
cardiac arrest due to local anesthetic toxicity.
131. • Increasing evidence suggests that the intravenous (IV)
infusion of lipid emulsions can reverse the cardiac
and neurologic effects of local-anesthetic toxicity.
Although no blinded studies have been conducted in
humans, studies in animal models and multiple case
reports in human patients have shown favorable results.
Indeed, case reports support the early use of lipid
emulsion at the first sign of arrhythmia, prolonged
seizure activity, or rapid progression of toxic
manifestations in patients with suspected local
anesthetic toxicity.
132. • Infrequently, local anesthetics may provoke an allergic
or hematologic reaction. Allergic reactions can be
treated with diphenhydramine or, for more serious
reactions, epinephrine or corticosteroids.
• Methemoglobinemia should initially be treated
symptomatically.
Subsequent treatment is guided by blood levels of
methemoglobin; methylene blue and hyperbaric oxygen
may be required in severe cases.
133. • Local ischemic or nerve toxicities may occur, particularly in the
extremities with prolonged anesthesia or use of agents
containing epinephrine. Suspected nerve damage should prompt
neurologic consultation for urgent peripheral nerve studies. If
vascular compromise, such as limb ischemia, is suspected,
consult a vascular surgeon immediately. Therapy for
extravasation (eg, warm compresses, phentolamine,
nitroglycerin cream) should be initiated for localized vascular
toxicity.
• Patients with persistent or unresolved significant reactions
require admission to a monitored bed for observation, further
evaluation, and treatment. Patients who are stable and have
minor or easily controlled adverse reactions can be discharged
and monitored on an outpatient basis.
134. • Finally, the prevention of local anesthetic toxicity
should always be the primary consideration.
• Although all adverse reactions cannot be anticipated,
complications can be minimized by strict adherence to
the guidelines of anesthetic dosing, identification of
patients at increased risk, and implementation of
appropriate anesthetic application techniques to avoid
unintentional intravascular injection.
135. Prevention of local anesthetic toxicity
• The following suggestions may help avoid complications related to local
anesthetic use, especially in emergency department patients:
• Consider obtaining and documenting informed consent in individuals with a prior history of
anesthetic reactions
• Document the amount and type of anesthetic used during the procedure
• Always obtain an adequate history and physical examination to identify risk factors and allergies
• Do not use class IB antidysrhythmics (including phenytoin) for seizures or dysrhythmias believed to
be due to cocaine toxicity
• Consider changes in neurologic signs or symptoms as a possible manifestation of anesthetic toxicity
• Admit patients with serious or unresolved symptoms
• Know the toxic dose of the local anesthetic being used. Use the lowest concentration and volume of
local anesthetic that still produces good results. Add epinephrine at a ratio of 1:200,000 to slow
vascular uptake through vasoconstriction.
136. • Describe the early symptoms of local anesthetic overdose
to patients and instruct them to inform the physician if
they experience any of these effects. Be sure that patients
understand the effects of local anesthetics and that they
should tell the physician if symptoms occur.
• A careful injection method may help prevent toxic
reactions. Perform high-volume (>5 mL) injections
slowly, in 3-mL increments. Stop to aspirate and observe
for blood in the syringe after every 3 mL injected.
(Injecting local anesthetic in this manner reduces the
chances of a large-volume intravascular injection.)
137. • Maintain verbal contact with the patient during the
procedure. This helps detect subtle symptoms, such as
dysarthria, as well as more severe ones, such as
changes in mental status.
• Because benzodiazepines raise the threshold for CNS
symptoms but not for cardiovascular symptoms, heavy
benzodiazepine premedication is likely to result in a
patient progressing directly to cardiovascular toxicity
without showing preliminary signs of CNS toxicity
138. In general
prevention of systemic complications :
Prior to Treatment
1. Complete review of medical status (including vital
signs)
2. Anxiety / Fear should be assessed and managed
before administering anesthetic
139. • Administration of Anesthetic
1. Place pt. supine or semi-supine position
2. Dry site, apply topical X 1 min
3. Select appropriate drug for treatment (time)
4. Vasoconstrictor unless contraindicated
5. Weakest anesthetic in the minimum volume
(compatible with successful anesthesia)
140. 6. Inject slowly (minimum of 60 sec / 1.8 ml)
7. Continually observe –
Never leave patient alone after injection
8. Use only aspirating syringe
9. Aspirate in two planes, before injecting
10. Use sharp, disposable needles of adequate
diameter and length
141. Dosage guidelines
Lower concentrations of local anesthetics are typically
used for infiltration anesthesia.
• Variation in local anesthetic dose depends on the
procedure, the degree of anesthesia required, and
individual patient circumstances. Use of a reduced dose
is indicated in the following patients:
• Debilitated or acutely ill patients
• Very young children or geriatric patients
• Patients with liver disease, atherosclerosis, or occlusive
arterial disease
142. The table below lists maximum recommended doses and toxic limits for
the most common anesthetics (from Malamed Handbook of Local
Anesthetics)
Drug Toxic Limit Maximum
2% Lidocaine
(Xylocaine)
2 mg/lb 300 mg
3%
Carbocaine(Mepivacaine
)
2 mg/lb 300 mg
4% Citanest (Prilocaine) 2.7 mg/lb 400 mg
1.5% Duranest
(Etidocaine)
3.6mg/lb 400 mg
0.5% Marcaine
(Bupivacaine)
0.6mg/lb 90 mg
Editor's Notes
R/O = rule out
Patients under 6 years and over 65 years of age - Absorption, metabolism, and excretion are not fully developed before age 6, and these functions diminish after age 65.
A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
Acidosis increases the risk because it favors dissociation of lidocaine from plasma proteins.
Low plasma potassium levels and acidosis also potentiate adverse effects of local anesthetics on the myocardium .
The binding of oxygen to methemoglobin results in an increased affinity for oxygen in the remaining heme sites that are in ferrous state within the same tetrameric hemoglobin unit.[1] This leads to an overall reduced ability of the red blood cell to release oxygen to tissues, with the associated oxygen–hemoglobin dissociation curve therefore shifted to the left. When methemoglobin concentration is elevated in red blood cells, tissue hypoxia may occur.